ANDA 90470, held by Barr. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 90470 (Phentermine Hydrochloride), held by Barr, was first approved by FDA on Aug 31, 2009, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride37.5MG · tablet;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jan 7, 2013 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jan 7, 2013 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 31, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters